Arcutis Biotherapeutics ARQT
NASDAQ ARQT
$28.10 +0.72 (+2.63%)
As of: Nov 11, 2026 · 3:23 PM EST

Arcutis Biotherapeutics (ARQT) Return on Capital Employed [ROCE] (2020 - 2026)

Updated

Arcutis Biotherapeutics (ARQT) reported Return on Capital Employed [ROCE] of 10.91% for Q2 2026, up 46.04 percentage points from -35.13% a year earlier and up 9.78 percentage points from the prior quarter.

Analysis

Arcutis Biotherapeutics (ARQT) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends

For FY2025, Arcutis Biotherapeutics posted Return on Capital Employed [ROCE] of -4.68%, up 43.93 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has increased for three consecutive years, with a five-year change of +71.21 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -48.61% in FY2024 (+20.54 pp), -69.15% in FY2023 (+8.01 pp), -77.16% in FY2022 (-12.60 pp) and -64.56% in FY2021 (+11.33 pp).
  • The Q2 2026 figure ranks as the highest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2020.
  • Year over year, Return on Capital Employed [ROCE] has now increased in each of the last ten quarters, with an average year-over-year change of +34.23 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q2 2024 (a gain of 57.07 percentage points); the low point was Q2 2022 (a drop of 49.95 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at 1.13% (Q1 2026), -4.49% (Q4 2025) and -14.60% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Arcutis Biotherapeutics 3.45 Bn 2.51 Bn 131.46 Mn 10.52%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 10.52%
Jun 30, 2026 10.91%
Mar 31, 2026 1.13%
Dec 31, 2025 -4.49%
Sep 30, 2025 -14.60%
Jun 30, 2025 -35.13%
Mar 31, 2025 -47.50%
Dec 31, 2024 -41.14%
Sep 30, 2024 -67.73%
Jun 30, 2024 -43.81%
Mar 31, 2024 -54.17%
Dec 31, 2023 -89.13%
Sep 30, 2023 -93.74%
Jun 30, 2023 -100.89%
Mar 31, 2023 -83.55%
Dec 31, 2022 -68.35%
Sep 30, 2022 -82.83%
Jun 30, 2022 -84.26%
Mar 31, 2022 -65.99%
Dec 31, 2021 -56.70%
API Access

Arcutis Biotherapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ARQT&period=max&api_key=YOUR_API_KEY